ConductScience.org, home

Paper486222

In vitro hexosamine depletion of intact articular cartilage by E-prostaglandins: prevention by chloroquine.

Fulkerson JP and 2 others. Arthritis Rheum, 1979. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro hexosamine depletion of intact articular cartilage by E-prostaglandins: prevention by chloroquine. Papers, record 486222. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/486222

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro hexosamine depletion of intact articular cartilage by E-prostaglandins: prevention by chloroquine.
PubMed
Journal
Arthritis Rheum
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.68
iCite
Revised in PubMed
2019-07-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fulkerson JPJ P
2Ladenbauer-Bellis IMI M
3Chrisman ODO D

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cartilage, ArticularMajor topic
ChloroquineMajor topic
HexosaminesMajor topic
Peptide HydrolasesMajor topic
Prostaglandins E, SyntheticMajor topic
Animals
Dogs
In Vitro Techniques
Knee Joint
RNA
Time Factors

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
32715647Hydroxychloroquine in rheumatic autoimmune disorders and beyond.EMBO Mol Med2020https://conductscience.org/library/papers/32715647PubMed
26246395Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.Inflammopharmacology2015https://conductscience.org/library/papers/26246395PubMed
7724995Influence of interleukin-1 beta, tumour necrosis factor alpha and prostaglandin E2 on chondrogenesis and cartilage matrix breakdown in vitro.Rheumatol Int1995https://conductscience.org/library/papers/7724995PubMed
7159397Adenylate cyclase of human articular chondrocytes. Responsiveness to prostaglandins and other hormones.Biochem J1982https://conductscience.org/library/papers/7159397PubMed
6287562Lysosomal elastase: effect on mechanical and biochemical properties of normal cartilage, inhibition by polysulfonated glycosaminoglycan, and binding to chondrocytes.Rheumatol Int1981https://conductscience.org/library/papers/6287562PubMed
3472453Differences in prostanoid production between healthy and rheumatic synovia in vitro.Agents Actions1987https://conductscience.org/library/papers/3472453PubMed
2786669Effects of diclofenac, indomethacin, tolfenamic acid and hydrocortisone on prostanoid production in healthy and rheumatic synovial cells.Agents Actions1989https://conductscience.org/library/papers/2786669PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/486222

GET https://conductscience.org/api/papers/v1/486222/authors